STEMCELL Technologies– tag –
-
Cell Culture Technology
Scaling the Future of Medicine: RoosterBio and Applied StemCell Partner on iPSC Bioprocess Solutions
PRNewswire USA Overview RoosterBio and Applied StemCell have announced a strategic partnership aimed at advancing scalable induced pluripotent stem cell (iPSC)-based bioprocess solutions. This collaboration integrates Applied StemCell's ... -
Cell Culture Technology
Syntax Bio and Applied StemCell Partner to Accelerate Allogeneic Cell Therapies with GMP-Compliant Hypoimmune iPSCs and Cellgorithm Platform
CRISPR Medicine News USA Overview Syntax Bio and Applied StemCell have forged a strategic collaboration to propel next-generation regenerative medicine by advancing stem cell innovation. Applied StemCell will supply GMP-compatible hypoim... -
Cell Culture Technology
Syntax Bio & Applied StemCell Partner to Accelerate Allogeneic iPSC Therapies with Low-Immunogenicity Lines and Cellgorithm Platform
Manufacturing Chemist USA Overview Syntax Bio and Applied StemCell have formed a strategic partnership to accelerate programmable iPSC therapy development. This collaboration aims to address key challenges of immune recognition and manuf... -
New Technology
STEMCELL Technologies Supports Organoid Research with Standardized hPSC Lines and Differentiation Kits
STEMCELL Technologies Canada Overview STEMCELL Technologies offers high-quality human iPSC lines and differentiation kits, including the STEMdiff™ Intestinal Organoid Kit, to support diverse research applications such as organoid generat... -
New Technology
Organoid Revolution: 3D Models Set New Standard for Drug Discovery and Development
学術論文 (UU.DIVA-PORTAL.ORG) スウェーデン Overview Organoids are rapidly transforming drug discovery and development, serving as miniature 3D tissue models that offer significantly enhanced physiological relevance compared to traditiona... -
New Technology
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ...
1